Literature DB >> 17240051

Intrahepatic interleukin-8 production during disease progression of chronic hepatitis C.

Yoshiya Tachibana1, Yasunari Nakamoto, Naofumi Mukaida, Shuichi Kaneko.   

Abstract

The current study was designed to investigate the contribution of chemokines to the pathogenesis of chronic hepatitis C and hepatocellular carcinoma (HCC) by measuring the production of IL-8, monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1 alpha (MIP-1alpha). A solid-phase sandwich enzyme-linked immunosorbent assay (ELISA) was established to quantitate serum concentrations of the chemokines. Expression of chemokines in liver tissues was evaluated immunohistochemically using specific monoclonal antibodies. As the severity of chronic hepatitis escalated, serum IL-8 levels increased progressively. Moreover, in the hepatocellular carcinoma (HCC) patients, IL-8 concentrations were positively correlated with the macroscopic staging of HCC, and inversely correlated with the duration of the survival periods. The results demonstrate that IL-8 production may be augmented upon the malignant transformation of hepatocytes in chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17240051     DOI: 10.1016/j.canlet.2006.10.028

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  12 in total

1.  Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells.

Authors:  Liang Zhang; Huanyu Wang; Tianshu Yang; Zhifeng Su; Dan Fang; Yafeng Wang; Jiazhu Fang; Xinwei Hou; Yingying Le; Keqiang Chen; Ji Ming Wang; Shao Bo Su; Qing Lin; Qi Zhou
Journal:  Oncoimmunology       Date:  2015-08-24       Impact factor: 8.110

2.  Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration.

Authors:  Katharine M Irvine; Richard Skoien; Nilesh J Bokil; Michelle Melino; Gethin P Thomas; Dorothy Loo; Brian Gabrielli; Michelle M Hill; Matthew J Sweet; Andrew D Clouston; Elizabeth E Powell
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

3.  Therapeutic Potential of OMe-PS-miR-29b1 for Treating Liver Fibrosis.

Authors:  Virender Kumar; Vinod Kumar; Jiangtao Luo; Ram I Mahato
Journal:  Mol Ther       Date:  2018-09-01       Impact factor: 11.454

4.  Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways.

Authors:  Kelly Hudspeth; Matteo Donadon; Matteo Cimino; Elena Pontarini; Paolo Tentorio; Max Preti; Michelle Hong; Antonio Bertoletti; Silvio Bicciato; Pietro Invernizzi; Enrico Lugli; Guido Torzilli; M Eric Gershwin; Domenico Mavilio
Journal:  J Autoimmun       Date:  2015-08-30       Impact factor: 7.094

5.  Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia.

Authors:  So Youn Kim; David A Weinstein; Matthew F Starost; Brian C Mansfield; Janice Y Chou
Journal:  J Hepatol       Date:  2007-12-28       Impact factor: 25.083

6.  Investigation of the direct hepatic effects of intramuscular interleukin-8 injection in an experimental rabbit model.

Authors:  Mert Kestelli; Mehmet Guzeloglu; Ismail Yurekli; Habib Cakir; Yeliz Yilmaz; Eda Erdis; Saliha Aksun; Engin Tulukoğlu; Ragip Ortac
Journal:  Med Sci Monit Basic Res       Date:  2013-09-11

7.  Enhanced levels of interleukin-8 are associated with hepatitis B virus infection and resistance to interferon-alpha therapy.

Authors:  Kai Yang; Shi-He Guan; Hao Zhang; Ying Pan; Yuan-Yuan Wu; Ai-Hua Wang; Bei-Bei Sun
Journal:  Int J Mol Sci       Date:  2014-11-17       Impact factor: 5.923

8.  Interleukin-8 producing hepatocellular carcinoma with pyrexia.

Authors:  Norifumi Harimoto; Ken Shirabe; Tomoyuki Abe; Kiyoshi Kajiyama; Takashi Nagaie; Tomonobu Gion; Yousuke Kuroda; Yoshihiko Maehara
Journal:  HPB Surg       Date:  2009-08-23

Review 9.  Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases.

Authors:  Ting Liu; Yu Zhou; Kwang Suk Ko; Heping Yang
Journal:  Mediators Inflamm       Date:  2015-10-05       Impact factor: 4.711

10.  A systematic review and meta-analysis of evaluation of serum interleukin 8 levels in hepatocellular carcinoma.

Authors:  Ebrahim Shakiba; Masoud Sadeghi; Mohammad Shakiba
Journal:  Clin Exp Hepatol       Date:  2019-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.